Proton Pump Inhibitors—We Know Their Benefits, But What Are Their Risks? - Frankly Speaking Ep 316
0:00
9:03
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-316
Overview: While the benefits of proton pump inhibitors (PPIs) are widely known, the same cannot be said of the risks. These common medications are generally considered “safe,” but new data suggest the potential for long-term risks. Join us to discuss these long-term risks of PPI use and whether some of your patients should step down from PPIs to H2RAs.
Episode resource links:
- Gut : 28 September 2020. doi: 10.1136/gutjnl-2020-322557
- Gut 2022 Jan; 71:16. (https://doi.org/10.1136/gutjnl-2021-325097)
- Front Pharmacol. 2022 Sep 14;13:979215. doi: 10.3389/fphar.2022.979215. eCollection 2022
Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato
Otros episodios de "Frankly Speaking About Family Medicine"
No te pierdas ningún episodio de “Frankly Speaking About Family Medicine”. Síguelo en la aplicación gratuita de GetPodcast.